Fox Business - The Power to Prosper
Search Site

Johnson & Johnson

Airlines 2014 market bright spot

FBN’s Cheryl Casone on the year in the markets.

Read More

  1. Court reverses $482 million stent case against Cordis

    Cordis Corp, a Johnson and Johnson subsidiary, did not infringe on a patent owned by a radiologist in making its Cypher stents, an appeals court said on Thursday, re...

  2. Court reverses $482 million case against JNJ's Cordis

    Cordis Corp, a Johnson and Johnson subsidiary, did not infringe upon a stent patent owned by a radiologist, an appeals court said on Thursday, reversing a ruling by ...

  3. Amgen Details Plan to Fight Patent Cliff, Lifts 2013 View

    Amgen Inc. (AMGN) said it will aggressively seek revenue over the next few years from international markets and by launching copycat drugs as the company prepares fo...

  4. J&J shops U.S. feminine pads unit, wants to keep K-Y: sources

    Johnson and Johnson is looking to sell most of its U.S. feminine hygiene business, as it seeks to exit low-growth areas, but wants to keep its K-Y brand, said three ...

  5. MARKET SNAPSHOT: U.S. Stocks Retreat From Five-year Highs

    U.S. stocks on Tuesday mostly retreated from five-year highs after home sales unexpectedly fell in December and Dow component Johnson & Johnson lowered 2013 guidance...

  6. MARKET SNAPSHOT: U.S. Stocks Start Near Five-year Highs

    U.S. stocks opened little changed, trading near five-year highs, on Tuesday amid corporate results that had Dow components Johnson & Johnson lowering 2013 guidance a...

  7. George Gilder: Low Tax Rates Bring More Revenue

    Economist George Gilder on efforts to avoid the fiscal cliff and the importance of Israel to the U.S. economy.

  8. Is the Market Over-Reacting to the Election?

    Profit Investments’ Eugene Profit and Premier Wealth/First Allied Securities Senior Wealth Strategist Mark Martiak discuss factors weighing on the markets.

  9. Week Ahead: Earnings and Economic Data

    Third-quarter earnings season kicks into high gear next week with earnings reports from several financial and technology bellwethers. Also due are economic reports f...

  10. Bayer Backs Xarelto Sales Forecast After FDA Panel Votes Against Expanded Use

    German pharmaceutical company Bayer AG (BAYN.XE) Thursday confirmed it sees peak annual sales of its Xarelto drug above EUR2 billion after a U.S. Food and Drug Admin...

  11. Gold Hits 5-Month Low

    FBN’s Nicole Petallides breaks down the day in the markets.

  12. J&J Fined $1 Billion over Risperdal

    Attorney Mark Lanier on the upcoming case against the pharmaceutical giant.

  1. Johnson & Johnson CEO on innovation

    Johnson & Johnson CEO Alex Gorsky says there are a number of areas where sensors will play a major role in health care.

  2. IBM’s Watson transforms R&D through cognitive computing

    IBM Watson Group vice president John Gordon outlines Watson’s new developments.

  3. Great jobs report propels Dow

    FBN’s Nicole Petallides on the Dow, S&P 500 and Nasdaq highs.

  4. Is the market overdue for a correction?

    Richmond Brothers founder David Richmond, The Haverford Trust Company CIO Hank Smith and United Futures Trading Co. Senior Broker Gary Kozlowski on the outlook for stocks.

  5. Tips for refining your portfolio

    Fairfax Global Market CEO Paul Dietrich and Adelphi University professor Michael Driscoll on trading oil and refiner stocks.

  6. Aveo: Anatomy of a trade gone wrong

    Riding on the back of a strong market, the TenStocks portfolio racked up decent year-to-date gains coming into late April. As qualifying investments became harder to...

  7. Philips to Pay $4.5 Million To Settle FCPA Allegations

    Dutch electronics giant Koninklijke Philips Electronics NV (PHG, PHIA.AE) agreed to pay U.S. regulators $4.5 million to resolve allegations of foreign bribery, a spo...

‹ Prev12345Next ›
Freebase CC-BY
Source: Johnson & Johnson on Freebase, licensed under CC-BY
Other content from Wikipedia, licensed under the GFDL